|
US753653A
(en)
|
1903-09-14 |
1904-03-01 |
American Car & Foundry Co |
Hopper-bottom car.
|
|
US6846968B1
(en)
|
1988-02-26 |
2005-01-25 |
Large Scale Biology Corporation |
Production of lysosomal enzymes in plants by transient expression
|
|
US5179023A
(en)
|
1989-03-24 |
1993-01-12 |
Research Corporation Technologies, Inc. |
Recombinant α-galactosidase a therapy for Fabry disease
|
|
US5356804A
(en)
|
1990-10-24 |
1994-10-18 |
Mount Sinai School Of Medicine Of The City Of New York |
Cloning and expression of biologically active human α-galactosidase A
|
|
US5834252A
(en)
|
1995-04-18 |
1998-11-10 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US20060257890A1
(en)
|
1996-05-20 |
2006-11-16 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US6117679A
(en)
|
1994-02-17 |
2000-09-12 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6335160B1
(en)
|
1995-02-17 |
2002-01-01 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US6995017B1
(en)
|
1994-02-17 |
2006-02-07 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US5837458A
(en)
|
1994-02-17 |
1998-11-17 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US6406855B1
(en)
|
1994-02-17 |
2002-06-18 |
Maxygen, Inc. |
Methods and compositions for polypeptide engineering
|
|
US5928905A
(en)
|
1995-04-18 |
1999-07-27 |
Glaxo Group Limited |
End-complementary polymerase reaction
|
|
US6309883B1
(en)
|
1994-02-17 |
2001-10-30 |
Maxygen, Inc. |
Methods and compositions for cellular and metabolic engineering
|
|
US6395547B1
(en)
|
1994-02-17 |
2002-05-28 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6165793A
(en)
|
1996-03-25 |
2000-12-26 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
CN101659926A
(zh)
|
1994-06-30 |
2010-03-03 |
诺沃奇梅兹有限公司 |
非毒性、非产毒性、非致病性镰孢属表达系统及所用启动子和终止子
|
|
FI104465B
(fi)
|
1995-06-14 |
2000-02-15 |
Valio Oy |
Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
|
|
US6506602B1
(en)
|
1996-03-25 |
2003-01-14 |
Maxygen, Inc. |
Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
|
|
US6096548A
(en)
|
1996-03-25 |
2000-08-01 |
Maxygen, Inc. |
Method for directing evolution of a virus
|
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
|
US6083725A
(en)
|
1996-09-13 |
2000-07-04 |
Transkaryotic Therapies, Inc. |
Tranfected human cells expressing human α-galactosidase A protein
|
|
MX340738B
(es)
|
1996-09-13 |
2016-07-22 |
Shire Human Genetic Therapies |
Terapia para deficiencia de a-galactosidasa a.
|
|
KR100570935B1
(ko)
|
1997-01-17 |
2006-04-13 |
맥시겐, 인크. |
반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법
|
|
US6326204B1
(en)
|
1997-01-17 |
2001-12-04 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
US7148054B2
(en)
|
1997-01-17 |
2006-12-12 |
Maxygen, Inc. |
Evolution of whole cells and organisms by recursive sequence recombination
|
|
IL135578A0
(en)
|
1997-10-29 |
2001-05-20 |
Genzyme Corp |
Compositions and methods for treating lysosomal storage disease
|
|
US6537746B2
(en)
|
1997-12-08 |
2003-03-25 |
Maxygen, Inc. |
Method for creating polynucleotide and polypeptide sequences
|
|
US6365408B1
(en)
|
1998-06-19 |
2002-04-02 |
Maxygen, Inc. |
Methods of evolving a polynucleotides by mutagenesis and recombination
|
|
JP4221100B2
(ja)
|
1999-01-13 |
2009-02-12 |
エルピーダメモリ株式会社 |
半導体装置
|
|
US6917882B2
(en)
|
1999-01-19 |
2005-07-12 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
US6376246B1
(en)
|
1999-02-05 |
2002-04-23 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US6436675B1
(en)
|
1999-09-28 |
2002-08-20 |
Maxygen, Inc. |
Use of codon-varied oligonucleotide synthesis for synthetic shuffling
|
|
US6368861B1
(en)
|
1999-01-19 |
2002-04-09 |
Maxygen, Inc. |
Oligonucleotide mediated nucleic acid recombination
|
|
US7702464B1
(en)
|
2001-08-21 |
2010-04-20 |
Maxygen, Inc. |
Method and apparatus for codon determining
|
|
US7024312B1
(en)
|
1999-01-19 |
2006-04-04 |
Maxygen, Inc. |
Methods for making character strings, polynucleotides and polypeptides having desired characteristics
|
|
ES2341217T3
(es)
|
1999-01-19 |
2010-06-17 |
Maxygen, Inc. |
Recombinacion de acidos nucleicos mediada por oligonucleotidos.
|
|
US6961664B2
(en)
|
1999-01-19 |
2005-11-01 |
Maxygen |
Methods of populating data structures for use in evolutionary simulations
|
|
AU3391900A
(en)
|
1999-03-05 |
2000-09-21 |
Maxygen, Inc. |
Encryption of traits using split gene sequences
|
|
US7430477B2
(en)
|
1999-10-12 |
2008-09-30 |
Maxygen, Inc. |
Methods of populating data structures for use in evolutionary simulations
|
|
US6519065B1
(en)
|
1999-11-05 |
2003-02-11 |
Jds Fitel Inc. |
Chromatic dispersion compensation device
|
|
EP1272967A2
(en)
|
2000-03-30 |
2003-01-08 |
Maxygen, Inc. |
In silico cross-over site selection
|
|
AU2001269923A1
(en)
|
2000-06-19 |
2002-01-02 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
JP5319865B2
(ja)
|
2002-03-01 |
2013-10-16 |
コデクシス メイフラワー ホールディングス， エルエルシー |
機能的生体分子を同定する方法、システム、およびソフトウェア
|
|
US20050084907A1
(en)
|
2002-03-01 |
2005-04-21 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
US7747391B2
(en)
|
2002-03-01 |
2010-06-29 |
Maxygen, Inc. |
Methods, systems, and software for identifying functional biomolecules
|
|
EP1488335A4
(en)
|
2002-03-09 |
2006-11-15 |
Maxygen Inc |
OPTIMIZING CROSSOVER POINTS FOR THE ADJUSTED EVOLUTION
|
|
DK1503788T3
(da)
|
2002-04-25 |
2011-10-17 |
Shire Human Genetic Therapies |
Behandling af alpha-galactosidase A-deficiens
|
|
EP2886658A1
(en)
|
2005-03-10 |
2015-06-24 |
BASF Enzymes LLC |
Lyase enzymes, nucleic acids encoding them and methods for making and using them
|
|
US7534595B2
(en)
|
2006-06-12 |
2009-05-19 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7531341B1
(en)
|
2006-06-12 |
2009-05-12 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of using compositions thereof
|
|
US7560263B2
(en)
|
2007-08-17 |
2009-07-14 |
Biomarin Pharmaceutical Inc. |
Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof
|
|
US8504498B2
(en)
|
2008-02-12 |
2013-08-06 |
Codexis, Inc. |
Method of generating an optimized, diverse population of variants
|
|
EP2250594B1
(en)
|
2008-02-12 |
2017-04-19 |
Codexis, Inc. |
Method of generating an optimized, diverse population of variants
|
|
DK3023494T3
(en)
|
2008-06-13 |
2019-02-25 |
Codexis Inc |
PROCEDURE FOR SYNTHESIS OF POLYNUCLEOTIDE VARIETIES
|
|
US20090312196A1
(en)
|
2008-06-13 |
2009-12-17 |
Codexis, Inc. |
Method of synthesizing polynucleotide variants
|
|
US8383346B2
(en)
|
2008-06-13 |
2013-02-26 |
Codexis, Inc. |
Combined automated parallel synthesis of polynucleotide variants
|
|
US9194011B2
(en)
|
2009-11-17 |
2015-11-24 |
Protalix Ltd. |
Stabilized alpha-galactosidase and uses thereof
|
|
US8876066B1
(en)
|
2009-12-17 |
2014-11-04 |
Progressive Fastening, Inc. |
Hanger with bolt closures
|
|
ES2690542T3
(es)
|
2010-02-04 |
2018-11-21 |
Biomarin Pharmaceutical Inc. |
Método para purificar variantes de fenilalanina amoníaco-liasa procariotas
|
|
SI2865751T1
(sl)
|
2010-03-02 |
2017-01-31 |
Protalix Ltd. |
Stabilizirana alfa-galaktozidaza in njene uporabe
|
|
RU2013154295A
(ru)
|
2011-06-08 |
2015-07-20 |
Шир Хьюман Дженетик Терапис, Инк. |
КОМПОЗИЦИИ ЛИПИДНЫХ НАНОЧАСТИЦ И СПОСОБЫ ДЛЯ ДОСТАВКИ мРНК
|
|
DK2726651T3
(en)
|
2011-06-28 |
2019-01-28 |
Codexis Inc |
PROTEIN INVARIANT GENERATION BY REGION SHUFFLING
|
|
EP2825647A4
(en)
|
2012-03-15 |
2015-10-14 |
Codexis Inc |
METHODS OF GENE REARRANGING
|
|
WO2013156552A1
(en)
*
|
2012-04-18 |
2013-10-24 |
Vib Vzw |
Means and methods for generating improved proteins
|
|
US9665694B2
(en)
|
2013-01-31 |
2017-05-30 |
Codexis, Inc. |
Methods, systems, and software for identifying bio-molecules with interacting components
|
|
RU2016116253A
(ru)
|
2013-09-27 |
2017-11-01 |
Кодексис, Инк. |
Автоматизированный скрининг вариантов фермента
|
|
BR112016006284B1
(pt)
|
2013-09-27 |
2022-07-26 |
Codexis, Inc |
Método implementado por computador, produto de programa de computador, e, sistema de computador
|
|
US9909113B2
(en)
|
2014-06-12 |
2018-03-06 |
Research Foundation Of The City University Of New York |
Purification of recombinant alpha galactosidase A
|
|
LT3237621T
(lt)
|
2014-12-22 |
2023-09-25 |
Codexis, Inc. |
Žmogaus alfa-galaktozidazės variantai
|
|
US20170051267A1
(en)
*
|
2015-08-20 |
2017-02-23 |
Research Foundation Of The City University Of New York |
Novel alpha-galactosidase a derivatives
|
|
WO2017201328A1
(en)
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
POLYNUCLEOTIDES ENCODING α-GALACTOSIDASE A FOR THE TREATMENT OF FABRY DISEASE
|
|
US11357834B2
(en)
|
2017-01-10 |
2022-06-14 |
Amicus Therapeutics, Inc. |
Recombinant α-galactosidase A for treatment of Fabry disease
|
|
CN111511910B
(zh)
|
2017-12-22 |
2024-11-08 |
韩美药品株式会社 |
具有新颖结构的治疗酶融合蛋白及其用途
|
|
AU2019403323B2
(en)
|
2018-12-20 |
2026-02-26 |
Codexis, Inc. |
Human alpha-galactosidase variants
|
|
KR20220044560A
(ko)
*
|
2019-08-07 |
2022-04-08 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
Gla 유전자에 돌연변이를 갖는 환자에서 파브리 질병을 치료하는 방법
|
|
CA3173294A1
(en)
|
2020-02-28 |
2021-09-02 |
Codexis, Inc. |
Human alpha-galactosidase variants
|
|
AU2023331251A1
(en)
|
2022-08-25 |
2025-02-27 |
Takeda Pharmaceutical Company Limited |
Composition for use in the treatment of fabry disease
|